101 related articles for article (PubMed ID: 4395426)
1. The influence of psychotropic drugs on the level and metabolism of noradrenaline in brain and behavior of rats.
Herman ZS
Arch Immunol Ther Exp (Warsz); 1970; 18(5):571-83. PubMed ID: 4395426
[No Abstract] [Full Text] [Related]
2. In vivo effects of typical and atypical antidepressants on brain noradrenergic system: behavioural correlations.
Racagni G; Mocchetti I; De Angelis L; Baraldi M; Cuomo E
Adv Biochem Psychopharmacol; 1982; 31():185-97. PubMed ID: 6282054
[No Abstract] [Full Text] [Related]
3. [Importance of noradrenaline in the mechanism of action of psychotropic drugs].
Vysotskaia NB; Sharov PA; Shugina TM
Biull Eksp Biol Med; 1968 Oct; 66(10):54-7. PubMed ID: 4394038
[No Abstract] [Full Text] [Related]
4. In vivo studies on central noradrenergic synaptic mechanisms after acute and chronic antidepressant drug treatment: biochemical and behavioral comparison.
Racagni G; Mocchetti I; Renna G; Cuomo V
J Pharmacol Exp Ther; 1982 Oct; 223(1):227-34. PubMed ID: 7120121
[No Abstract] [Full Text] [Related]
5. Iprindole-amphetamine interactions in the rat: the role of aromatic hydroxylation of amphetamine in its mode of action.
Freeman JJ; Sulser F
J Pharmacol Exp Ther; 1972 Nov; 183(2):307-15. PubMed ID: 4673401
[No Abstract] [Full Text] [Related]
6. Relationship of dopamine neural systems to the behavioral alterations produced by 6-hydroxydopamine administration into brain.
Cooper BR; Breese GR
Adv Biochem Psychopharmacol; 1974; 12(0):353-68. PubMed ID: 4609223
[No Abstract] [Full Text] [Related]
7. Central action of 11-(3-dimethylaminopropylidene)-6,11-dihydro-dibenzo-(b,e)oxepine hydrocholoride (doxepine).
Zieliński M; Janiec W; Herman ZS
Pol J Pharmacol Pharm; 1973; 25(1):17-22. PubMed ID: 4149574
[No Abstract] [Full Text] [Related]
8. On the mechanism of antidepressant-like action of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
[TBL] [Abstract][Full Text] [Related]
9. A study of the central effects of 5,6-dihydroxytryptamine.
Longo VG; Scotti de Carolis A; Liuzzi A; Massotti M
Adv Biochem Psychopharmacol; 1974; 10():109-20. PubMed ID: 4546514
[No Abstract] [Full Text] [Related]
10. Stereospecificity of behavioural and biochemical responses to oxaprotiline--a new antidepressant.
Delini-Stula A; Hauser K; Baumann P; Olpe HR; Waldmeier P; Storni A
Adv Biochem Psychopharmacol; 1982; 31():265-75. PubMed ID: 6282056
[No Abstract] [Full Text] [Related]
11. Effect of tricyclic antidepessants on attack elicited by hypothalamic stimulation: relation to brain biogenic amines.
Dubinsky B; Karpowicz JK; Goldberg ME
J Pharmacol Exp Ther; 1973 Dec; 187(3):550-7. PubMed ID: 4272322
[No Abstract] [Full Text] [Related]
12. Spectra of psychotropic activity and neurochemical mechanisms of action of bi- and tetracyclic antidepressants.
Kozlovskaya MM; Avdulov NA; Kushnaryov VV
Ann Ist Super Sanita; 1982; 18(1):83-6. PubMed ID: 6133492
[No Abstract] [Full Text] [Related]
13. Studies on the accumulation of O-methylated dopamine and noradrenaline in the rat brain following various neuroleptics, thymoleptics and aceperone.
Scheel-Krüger J
Arch Int Pharmacodyn Ther; 1972 Feb; 195(2):372-8. PubMed ID: 5015941
[No Abstract] [Full Text] [Related]
14. Some persistent effects of the pre- and neonatal administration of psychotropic drugs on noradrenaline metabolism in discrete areas of rat brain.
Tonge SR; Leonard BE
Br J Pharmacol; 1973 Jun; 48(2):364P-365P. PubMed ID: 4739053
[No Abstract] [Full Text] [Related]
15. The involvement of serotonin and noradrenaline in the psychopathological processes of stress and depression: animal models and the effect of antidepressant drugs.
Płaźnik A; Kostowski W
Pol J Pharmacol Pharm; 1991; 43(4):301-22. PubMed ID: 1811222
[No Abstract] [Full Text] [Related]
16. Depressant action of metabolities of noradrenaline and adrenaline in rats.
Herman Z; Drybanski A; Trzeciak HI
Arch Immunol Ther Exp (Warsz); 1973; 21(2):281-6. PubMed ID: 4741042
[No Abstract] [Full Text] [Related]
17. Interaction between antidepressants and alpha-adrenergic receptor blocking agents.
Zebrowska-Lupina I; Kozyrska C; Stelmasiak M
Pol J Pharmacol Pharm; 1980; 32(5):673-80. PubMed ID: 6115370
[TBL] [Abstract][Full Text] [Related]
18. Dopamine, noradrenaline and 5-hydroxy-tryptamine in relation to motor activity, fighting and mounting behavior. I. L-dopa and DL-threo-dihydroxyphenylserine in combination with Ro 4-4602, pargyline and reserpine.
Benkert O; Gluba H; Matussek N
Neuropharmacology; 1973 Mar; 12(3):177-86. PubMed ID: 4735415
[No Abstract] [Full Text] [Related]
19. Studies on the participation of the dopaminergic system in the central effects of chronically administered antidepressant drugs.
Kozyrska C; Zebrowska-Lupina I
Pol J Pharmacol Pharm; 1983; 35(2):115-26. PubMed ID: 6684769
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of clovoxamine, a new non-tricyclic antidepressant.
Claassen V; Boschman TA; Dhasmana KM; Hillen FC; Vaatstra WJ; Zwagemakers JM
Arzneimittelforschung; 1978; 28(10):1756-66. PubMed ID: 582680
[No Abstract] [Full Text] [Related]
[Next] [New Search]
